Education
About Us
Working with TipRanks
Follow Us
Innovative Industrial Properties (IIPR)
NYSE:IIPR
Top Page
Innovative Industrial Properties
(NYSE:IIPR)
Select Model
Select Model
Rating:78Outperform
Price Target:
$61.00
â–²(7.66% Upside)
Action:ReiteratedDate:03/04/26
The score is driven primarily by strong financial resilience (notably the very conservative balance sheet and healthy cash generation) and supportive technical uptrend signals. It is held back by weakening top-line/FFO-AFFO trends and earnings-call risks tied to tenant litigation/receiverships, refinancing needs, and variable re-leasing economics, which also temper the attractiveness of the high dividend yield.
Positive Factors
Conservative balance sheet
Extremely low leverage and a large unencumbered asset base give enduring financial flexibility. With zero debt in the TTM snapshot and >$2B unencumbered real estate, the company can absorb tenant stress, access secured borrowing, and fund re-leasing or opportunistic acquisitions without immediate equity dilution.
Strong cash generation & AFFO
Robust operating cash flow and recurring AFFO underpin distribution capacity and capital deployment. With OCF tracking net income (~$198M) and AFFO of ~$205M, the REIT sustains dividends, funds selective investments, and supports working liquidity despite cyclical tenant issues, helping preserve long-term shareholder returns.
Leasing and re-tenanting momentum
Material re-tenanting activity converts nonperforming assets into cash-generating leases and reduces vacancy risk. Large executed leases and a pipeline of >900k sq ft of LOIs indicate durable upside to rent roll and AFFO as receiverships resolve and properties re-enter stable operating leases over the next several quarters.
Negative Factors
Tenant credit & litigation risk
Ongoing receiverships and lawsuits create multi-quarter uncertainty around cash recovery and enforceability of leases. Legal processes delay rent collections, incur uncertain costs (no legal reserve noted), and can materially depress AFFO until outcomes finalize, making cash flow timing and predictability weaker.
Revenue and margin pressure
Declining top-line and compressed margins signal structural pressure on returns from the portfolio. Lower revenue and falling net margins reduce ROE and AFFO potential, reflecting weaker re-leasing economics and rent resets that can persist across leasing cycles and limit long-term earnings resilience.
Refinancing and funding obligations
Near-term maturities and remaining strategic commitments create persistent funding risk. The May 2026 bond maturity and the ~$120M remaining IQHQ funding obligation require market access or asset-backed financing; elevated preferred yields and revolver rates indicate higher long-run funding costs if markets tighten.
Innovative Industrial Properties (IIPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.51B
Dividend Yield13.07%
Average Volume (3M)303.34K
Price to Earnings (P/E)11.6
Beta (1Y)0.79
Revenue Growth-11.22%
EPS Growth-24.64%
CountryUS
Employees21
SectorReal Estate
Sector Strength53
IndustryREIT - Industrial
Share Statistics
EPS (TTM)1.06
Shares Outstanding28,135,864
10 Day Avg. Volume426,826
30 Day Avg. Volume303,340
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.72
Price to Sales (P/S)4.99
P/FCF Ratio7.59
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue7.13
Enterprise Value/Gross Profit9.54
Enterprise Value/Ebitda8.92
Forecast
1Y Price Target
$48.33Price Target Upside-14.70% Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)4.43
Revenue Forecast (FY)$264.24M
Innovative Industrial Properties Business Overview & Revenue Model
Company DescriptionInnovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.
How the Company Makes MoneyIIPR generates revenue primarily through long-term leases with cannabis operators, which are structured as sale-leaseback agreements. In these arrangements, IIPR purchases properties from cannabis companies and leases them back, allowing these operators to free up capital for operational purposes. The company typically earns rental income, which is a significant portion of its revenue. Additionally, IIPR may benefit from property appreciation and potential growth in the cannabis sector. The company's strategy also involves expanding its portfolio through new acquisitions and partnerships with cannabis operators, further enhancing its revenue streams.
Innovative Industrial Properties Key Performance Indicators (KPIs)
Any
Rentable Space
Measures the total square footage available for leasing, indicating potential revenue growth and capacity to expand tenant relationships.
Measures the total square footage available for leasing, indicating potential revenue growth and capacity to expand tenant relationships.
Data provided by:
The Fly
The FlyInnovative Industrial Properties Earnings Call Summary
Earnings Call Date:Feb 23, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call presented a mix of constructive operational and financial progress—improving AFFO, meaningful leasing and re-tenanting momentum, strong liquidity management and strategic life-science diversification—while notable legacy issues remain around troubled tenants, ongoing litigation/receiverships, one-time rent recoveries and near-term refinancing/legal uncertainties. Management emphasized execution progress and multiple tangible leasing wins that suggest earnings upside as receiverships conclude, but several risks (legal outcomes, refinancing, re-leasing rate variability and remaining IQHQ funding) persist.Q4-2025 Updates
Positive Updates
Full-Year Financial Results and Cash Flow
Full-year total revenues of $266 million and AFFO of $205 million; generated approximately $200 million of cash flows from operations in 2025; returned $1.1 billion to shareholders since inception.
Quarterly Improvement in AFFO
Q4 2025 AFFO of $53.3 million ($1.88 per share), a 10% improvement versus Q3 2025 AFFO of $1.71 per share; Q4 total revenues of $66.7 million.
Leasing and Re-tenanting Momentum
Executed new leases at 4 properties totaling ~339,000 sq ft in 2025 and progressed on leases/LOIs representing over 900,000 sq ft related to previously nonperforming assets (Forefront, Gold Flora, PharmaCann). Specific wins include 70k and 204k sq ft leases in Palm Springs/Desert Hot Springs and a tentative agreement for a 114k sq ft Washington property.
Capital Deployment and Strategic Investment
Committed ~$275 million in new investments in 2025, including a strategic investment in IQHQ; have funded $150 million of a $270 million commitment to IQHQ (≈55.6% funded) with $120 million remaining to be funded over time.
Improved Liquidity and Access to Capital
Exited the quarter with total liquidity exceeding $105–$107 million (cash + available revolvers); added a $100 million revolving credit facility secured by IQHQ at a 6.1% rate; raised over $145 million of attractively priced debt and preferred equity since October 2025.
Preferred Equity Issuances and Investor Demand
Issued approximately $5 million on ATM in Q4 2025 and raised over $40 million of preferred stock early in Q1 2026 at a yield of just over 9.5%; Series A preferred outstanding grown to $95 million of par value.
Balance Sheet Strength
Portfolio >$2.5 billion gross assets and over $2 billion of unencumbered real estate; conservative capital structure with debt service coverage >10x and net debt to adjusted EBITDA of 1.4x.
Portfolio Dispositions and Capital Recycling
Closed on 3 dispositions in 2025 (California, Colorado, Michigan) and sold a dispensary in Phoenix in early 2026 to opportunistically prune noncore assets and redeploy capital.
Legal Recovery Win
Obtained a $7 million judgment for unpaid rent and damages from former tenant Temescal Wellness (Massachusetts property).
Positive Life-Science Market Signals
Strategic life-science exposure supported by industry stabilization: construction pipeline down from >37M sq ft (2023 peak) to ~6M sq ft (an ≈83.8% decline), Boston annual new demand of 2.1M sq ft (≈72% increase vs 2024), and first Q4 vacancy decline in the San Francisco Peninsula in >2 years.
Negative Updates
Troubled Tenants and Ongoing Receiverships/Litigation
Ongoing receivership and legal proceedings for Gold Flora, Forefront and litigation with PharmaCann; deferred/unpaid rent historically required legal action and receivership processes that delay cash flows and recovery timing.
One-Off Payments Driving Near-Term Improvement
Q4 AFFO improvement was aided by $3.7 million ($0.13 per share) of payments from Gold Flora and a subsequent ~$3 million ($0.10 per share) recovery in early 2026 — indicating some near-term results reflect one-time recoveries rather than recurring operational improvement.
Re-leasing Rate Pressure on Some Assets
Re-leasing outcomes vary by asset; management noted instances where new rents are as much as ~50% below prior contract rates on a deal-by-deal basis, reflecting downside pressure in certain markets.
Legal Costs, SEC Involvement and No Reserve
Multiple legal matters (tenant litigation, receiverships, and SEC involvement noted in 10-K); company has not recorded a legal reserve and legal expenses are uncertain (historical average ~ $2 million/year), creating expense and outcome uncertainty.
Refinancing and Maturity Risk
Upcoming bond maturity at the end of May 2026 requires refinancing or other capital solutions; uncertainty remains despite strong unencumbered asset base.
Higher Cost of Capital for Some Funding
Preferred equity yield raised at just over 9.5% (reflects investor demand but higher cost of capital); new IQHQ-secured revolver carries a 6.1% rate — overall financing costs have notable expense implications.
Timing and Uncertainty of Cannabis Regulatory Changes
Executive order to reschedule cannabis to Schedule III is directionally positive but timing/implementation remain uncertain; potential intoxicating hemp regulatory changes expected November 2026 add near-term market uncertainty.
Remaining IQHQ Funding Obligation
Management has funded $150 million of its $270 million IQHQ commitment, leaving $120 million (≈44.4%) to be funded over time, which will require future capital deployment.
Company Guidance
Guidance for 2026 emphasizes opportunistic capital-market access and realization of earnings upside from re‑tenanting: management expects continued selective investment and re-leasing activity (over 900,000 sq ft of LOIs/leases in progress and 339,000 sq ft executed in 2025) to drive near‑term revenue recovery and dividend support, while continuing to deploy the IQHQ commitment (funded $150M of a $270M commitment, $120M remaining). Key metrics cited include total liquidity >$105M exiting the year (>$107M at quarter‑end), a new $100M revolving credit facility at 6.1% secured by the IQHQ investment, Series A preferred outstanding of $95M par, >$145M of debt and preferred raised since Oct 2025 (including >$40M of preferred at ~9.5% in early 2026), gross assets of >$2.5B, >$2B of unencumbered real estate, cash flow from operations ~ $200M in 2025, 2025 revenues $266M and AFFO $205M (Q4 revenues $66.7M; Q4 AFFO $53.3M or $1.88/sh, up 10% q/q), debt service coverage >10x and net debt to adjusted EBITDA 1.4x, and a construction pipeline of ~6M sq ft (down from a 2023 peak >37M), all of which management says position the company to capture near‑term leasing and capital market opportunities.Innovative Industrial Properties Financial Statement Overview
Summary
Strong underlying profitability and cash generation are supported by an unusually conservative balance sheet (including zero debt in the latest TTM snapshot). Offsetting this, revenue has slipped in the latest TTM, margins have compressed versus 2023–2024, and KPI commentary flags a material 2025 decline in FFO/AFFO that raises dividend durability risk despite improving late-2025 trends.Income Statement
Profitability remains a clear strength, with very high gross profitability and strong bottom-line profitability in the latest TTM (Trailing-Twelve-Months) period (net profit margin ~44%). However, momentum has weakened: revenue declined in the latest TTM (Trailing-Twelve-Months) (-3.7%) after being roughly flat in 2024 and down from the stronger growth years earlier. Margins also compressed versus 2023–2024 (net margin ~52–54% then), suggesting less favorable rent escalations/portfolio dynamics or higher costs relative to revenue.73
Positive
Balance Sheet
The balance sheet looks very conservative, highlighted by zero total debt in the latest TTM (Trailing-Twelve-Months) snapshot and a large equity base (~$1.85B) against total assets (~$2.37B). Even in prior years, leverage was modest (debt-to-equity ~0.15–0.20). The main trade-off is that returns on equity are moderate (TTM ~6.7%), and have eased versus 2023–2024 (~8.3–8.5%), reflecting softer earnings power rather than financial strain.88
Very Positive
Cash Flow
Cash generation is solid: operating cash flow in TTM (Trailing-Twelve-Months) (~$198M) closely tracks net income (free cash flow to net income ~0.92), and free cash flow growth is positive in the latest period (+4.9%). That said, cash flow has been volatile historically, with large negative free cash flow in 2020 and 2022, indicating periodic heavy investment/capex swings that can pressure cash available for distributions in certain years.76
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 265.95M | 308.52M | 309.51M | 276.36M | 204.55M |
| Gross Profit | 235.78M | 280.05M | 284.61M | 265.84M | 200.11M |
| EBITDA | 208.70M | 248.72M | 248.88M | 232.64M | 172.15M |
| Net Income | 114.44M | 161.66M | 165.59M | 154.39M | 113.99M |
Balance Sheet | |||||
| Total Assets | 2.37B | 2.38B | 2.39B | 2.41B | 2.08B |
| Cash, Cash Equivalents and Short-Term Investments | 47.60M | 146.25M | 140.25M | 87.12M | 81.10M |
| Total Debt | 393.70M | 297.87M | 300.88M | 301.50M | 326.09M |
| Total Liabilities | 522.85M | 441.99M | 438.12M | 452.94M | 472.90M |
| Stockholders Equity | 1.85B | 1.94B | 1.95B | 1.96B | 1.61B |
Cash Flow | |||||
| Free Cash Flow | 174.76M | 258.45M | 255.54M | -139.75M | 188.75M |
| Operating Cash Flow | 198.19M | 258.45M | 255.54M | 234.13M | 188.75M |
| Investing Cash Flow | -174.30M | -56.00M | -6.79M | -396.20M | -384.09M |
| Financing Cash Flow | -122.54M | -197.90M | -195.63M | 164.22M | 155.76M |
Innovative Industrial Properties Technical Analysis
Positive
56.66
Price Trends
49.55
Positive
50.57
Positive
51.67
Positive
Market Momentum
1.48
Negative
71.73
Negative
92.26
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IIPR, the sentiment is Positive. The current price of 56.66 is above the 20-day moving average (MA) of 49.31, above the 50-day MA of 49.55, and above the 200-day MA of 51.67, indicating a bullish trend. The MACD of 1.48 indicates Negative momentum. The RSI at 71.73 is Negative, neither overbought nor oversold. The STOCH value of 92.26 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IIPR.
Innovative Industrial Properties Risk Analysis
Innovative Industrial Properties disclosed 84 risk factors in its most recent earnings report. Innovative Industrial Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Innovative Industrial Properties Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $1.51B | 11.59 | 6.09% | 13.07% | -11.22% | -24.64% | |
71 Outperform | $7.54B | 25.24 | 7.75% | 4.02% | 9.62% | 31.08% | |
68 Neutral | $2.87B | 25.58 | 5.45% | 5.33% | 6.98% | 465.32% | |
67 Neutral | $8.56B | 24.05 | 9.27% | 2.98% | 9.66% | -23.17% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | $431.91M | -5.52 | -16.39% | 2.20% | 1.08% | 14.30% |
* Real Estate Sector Average
IIPR
Innovative Industrial Properties
56.66
-9.22
-13.99%
STAG
Stag Industrial
39.47
4.03
11.37%
FR
First Industrial Realty
62.45
6.30
11.21%
LXP
LXP Industrial Trust
49.23
5.47
12.51%
ILPT
Industrial Logistics Properties
6.60
2.80
73.64%
Innovative Industrial Properties Corporate Events
Business Operations and StrategyStock Buyback
Innovative Industrial Properties Announces New $100M Buyback Program
Positive
Mar 4, 2026
On March 3, 2026, Innovative Industrial Properties, Inc. approved a new share repurchase program authorizing the buyback of up to $100 million of its common stock, replacing its existing plan that was set to expire on March 17, 2026. The program, which runs through March 4, 2027, allows repurchases via open market, block trades, or private transactions under Rule 10b-18 and potentially a Rule 10b5-1 plan, giving management flexible tools to manage capital allocation and signal confidence in the company’s valuation, though there is no guarantee any specific amount of stock will be repurchased.
The most recent analyst rating on (IIPR) stock is a Hold with a $45.00 price target. To see the full list of analyst forecasts on Innovative Industrial Properties stock, see the IIPR Stock Forecast page.
Business Operations and StrategyDividendsFinancial DisclosuresPrivate Placements and Financing
Innovative Industrial Properties Reports 2025 Results, Grows Dividend
Positive
Feb 23, 2026
On February 23, 2026, Innovative Industrial Properties reported full-year 2025 revenues of $266.0 million, net income attributable to common stockholders of $114.4 million, and AFFO of $205.4 million, while continuing its track record of annual dividend growth with $7.60 per share declared for the year. The company advanced a diversification strategy through a committed investment of up to $270.0 million in life science platform IQHQ, raised $146 million of debt and preferred equity since October 2025, executed or signed leases covering roughly 337,000 square feet across multiple properties in late 2025 and early 2026, addressed tenant defaults with partial recoveries, and bolstered liquidity via a new $100.0 million secured revolving credit facility, collectively strengthening its balance sheet and reinforcing demand for its specialized real estate portfolio despite year-over-year declines in net income and AFFO.
The most recent analyst rating on (IIPR) stock is a Buy with a $56.00 price target. To see the full list of analyst forecasts on Innovative Industrial Properties stock, see the IIPR Stock Forecast page.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.